Mario Gabelli's PFE Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 580,331 shares of Pfizer Inc. (PFE) worth $14.45 M, representing 0.14% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2024, adding 295,139 shares. Largest reduction occurred in Q1 2016, reducing 169,945 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +17,027 | Add 3.02% | 580,331 | $24.90 |
| Q3 2025 | -107,937 | Reduce 16.08% | 563,304 | $25.48 |
| Q2 2025 | -122,695 | Reduce 15.45% | 671,241 | $24.24 |
| Q1 2025 | +28,572 | Add 3.73% | 793,936 | $25.34 |
| Q4 2024 | +87,621 | Add 12.93% | 765,364 | $26.53 |
| Q3 2024 | +97,078 | Add 16.72% | 677,743 | $28.94 |
| Q2 2024 | +47,414 | Add 8.89% | 580,665 | $27.98 |
| Q1 2024 | +295,139 | Add 123.95% | 533,251 | $27.75 |
| Q4 2023 | +84,907 | Add 55.42% | 238,112 | $28.79 |
| Q3 2023 | -595 | Reduce 0.39% | 153,205 | $33.17 |
| Q2 2023 | -3,816 | Reduce 2.42% | 153,800 | $36.68 |
| Q1 2023 | -7,143 | Reduce 4.34% | 157,616 | $40.80 |
| Q4 2022 | -14,070 | Reduce 7.87% | 164,759 | $51.24 |
| Q3 2022 | -21,746 | Reduce 10.84% | 178,829 | $43.76 |
| Q2 2022 | +7,877 | Add 4.09% | 200,575 | $52.43 |
| Q1 2022 | -2,929 | Reduce 1.50% | 192,698 | $51.77 |
| Q4 2021 | -9,591 | Reduce 4.67% | 195,627 | $59.05 |
| Q3 2021 | -6,134 | Reduce 2.90% | 205,218 | $43.01 |
| Q2 2021 | +19,397 | Add 10.10% | 211,352 | $39.16 |
| Q1 2021 | -6,023 | Reduce 3.04% | 191,955 | $36.23 |
| Q4 2020 | -18,829 | Reduce 8.68% | 197,978 | $36.81 |
| Q3 2020 | -19,040 | Reduce 8.07% | 216,807 | $36.70 |
| Q2 2020 | -67,337 | Reduce 22.21% | 235,847 | $32.70 |
| Q1 2020 | +42,073 | Add 16.11% | 303,184 | $32.64 |
| Q4 2019 | -23,313 | Reduce 8.20% | 261,111 | $39.18 |
| Q3 2019 | -8,428 | Reduce 2.88% | 284,424 | $35.93 |
| Q2 2019 | -9,840 | Reduce 3.25% | 292,852 | $43.32 |
| Q1 2019 | -6,839 | Reduce 2.21% | 302,692 | $42.47 |
| Q4 2018 | -11,280 | Reduce 3.52% | 309,531 | $43.65 |
| Q3 2018 | -21,569 | Reduce 6.30% | 320,811 | $44.07 |
| Q2 2018 | -45,121 | Reduce 11.64% | 342,380 | $36.28 |
| Q1 2018 | +1,470 | Add 0.38% | 387,501 | $35.49 |
| Q4 2017 | -91,095 | Reduce 19.09% | 386,031 | $36.22 |
| Q3 2017 | -7,233 | Reduce 1.49% | 477,126 | $35.70 |
| Q2 2017 | -1,107 | Reduce 0.23% | 484,359 | $33.59 |
| Q1 2017 | -4,982 | Reduce 1.02% | 485,466 | $34.21 |
| Q4 2016 | -11,938 | Reduce 2.38% | 490,448 | $32.48 |
| Q3 2016 | -15,555 | Reduce 3.00% | 502,386 | $33.87 |
| Q2 2016 | -19,070 | Reduce 3.55% | 517,941 | $35.21 |
| Q1 2016 | -169,945 | Reduce 24.04% | 537,011 | $29.64 |
| Q4 2015 | -23,049 | Reduce 3.16% | 706,956 | $32.28 |
| Q3 2015 | -89,896 | Reduce 10.96% | 730,005 | $31.41 |
| Q2 2015 | -76,530 | Reduce 8.54% | 819,901 | $33.53 |
| Q1 2015 | -55,152 | Reduce 5.80% | 896,431 | $34.79 |
| Q4 2014 | -71,998 | Reduce 7.03% | 951,583 | $31.15 |
| Q3 2014 | -80,489 | Reduce 7.29% | 1.02 M | $29.57 |
| Q2 2014 | -61,504 | Reduce 5.28% | 1.1 M | $29.68 |
| Q1 2014 | -18,169 | Reduce 1.53% | 1.17 M | $32.12 |
| Q4 2013 | -19,100 | Reduce 1.59% | 1.18 M | $30.63 |
| Q3 2013 | +150,555 | Add 14.31% | 1.2 M | $28.73 |
| Q2 2013 | +1.05 M | Add 0.00% | 1.05 M | $28.01 |
Mario Gabelli's Pfizer Investment FAQs
Mario Gabelli first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 1,052,288 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Pfizer Inc. (PFE) for 51 quarters since Q2 2013.
Mario Gabelli's largest addition to Pfizer Inc. (PFE) was in Q2 2013, adding 1,052,288 shares worth $29.48 M.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 580,331 shares of Pfizer Inc. (PFE), valued at approximately $14.45 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.14% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Pfizer Inc. (PFE) was 1,202,843 shares, as reported at the end of Q3 2013.